ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly u.S. Personal Consumption Expenditures: Health Care — SAAR ($B) (M)
U.S. Bureau of Economic Analysis via FRED (DHLCRC1Q027SBEA)
Latest, FY2025
3,569
Period ended Dec 31, 2025
Change on a year earlier
+7.3%
3,327 in FY2024
History
10 years
Since FY2016
Sources
1
FRED (DHLCRC1Q027SBEA)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Personal Consumption Expenditures: Health Care — SAAR ($B) (M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,569 | +7.3% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2024 | Dec 31, 2024 | 3,327 | +8.6% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2023 | Dec 31, 2023 | 3,064 | +8.7% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2022 | Dec 31, 2022 | 2,818 | +6.7% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2021 | Dec 31, 2021 | 2,642 | +12.2% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2020 | Dec 31, 2020 | 2,354 | -4.8% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2019 | Dec 31, 2019 | 2,472 | +5.4% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2018 | Dec 31, 2018 | 2,345 | +4.4% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2017 | Dec 31, 2017 | 2,245 | +3.7% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2016 | Dec 31, 2016 | 2,165 | – | FRED (DHLCRC1Q027SBEA) ↗ |
Cite this data
StockData. (2026). Eli Lilly U.S. Personal Consumption Expenditures: Health Care — SAAR ($B) (M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fred_pce_healthcare_saar
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.